crossover
    2004

    Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study

    Katzenschlager R, Evans A, Manson A

    Published in Journal of Neurology, Neurosurgery & Psychiatry

    Key Findings

    Mucuna seed powder gave faster onset and longer on-time than standard levodopa/carbidopa without increased dyskinesia.

    Conclusions

    Pharmacokinetic advantage over standard levodopa.

    Limitations

    Eight patients, acute dosing only.

    Supplements Studied

    Mucuna seed powder gave faster onset and longer on-time than standard levodopa/carbidopa.

    Related Health Concerns

    Parkinson's Disease

    Study Details

    Year:2004
    Sample Size:8
    Duration:1 weeks
    Quality Score:6/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.